CTLT

Catalent, Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
$63.48
+0.00 (+0.00%)
Mkt Cap: 11.52B
Key Metrics
MetricValue
P/E RatioN/A
EV/EBITDAN/A
ROEN/A
Gross MarginN/A
Revenue GrowthN/A
FCF Yield-0.6%
Dividend YieldN/A
Market Cap11.52B
Volume13.67M
Recent News
Scholar Rock drops Catalent facility from marketing application for muscle weakness drug
reuters.com · 2026-08-07
Taysha Gene Therapies and Catalent Expand Strategic Partnership to Include Future Commercial Manufacturing Support of TSHA-102 Gene Therapy for Rett Syndrome
globenewswire.com · 2026-08-03
Catalent Launches Qai™ to Reimagine Quality Assurance for its Manufacturing Services
businesswire.com · 2026-06-16

Unlock the Full Deep Scan

9 AI agents analyze CTLT across earnings, insider flow, macro conditions, corporate strategy, market microstructure, and price action.

Sign Up Free →